Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) EBT Margin (2022 - 2024)

Moolec Science (MLECW) posted EBT Margin of 81.21% for Q4 2024, up 34.94% sequentially from 124.82% in Q3 2024, and up 71982.0% YoY from N/an in Q1 2024.

Moolec Science (MLECW) EBT Margin (2022 - 2024) Analysis & Trends

Moolec Science has reported EBT Margin for 3 years, with the latest figure at 81.21% in Q4 2024.

  • Quarterly EBT Margin rose 71982.0% year-over-year to 81.21% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 110.09% (down 13511.0% YoY) and the FY2024 annual result came in at 148.61%, up 559953.0% from the prior year.
  • EBT Margin advanced to 81.21% in Q4 2024 per MLECW's latest filing, from 124.82% in the prior quarter.
  • Over five years, EBT Margin peaked at 6273.27% in Q3 2022 and troughed at 501839.99% in Q4 2022.
  • A 3-year average of 47159.45% and a median of 92.51% in 2023 frame the typical range for EBT Margin.
  • The widest YoY moves for EBT Margin: up 50103896 bps in 2023, down 637708 bps in 2023.
  • Over 3 years, EBT Margin stood at 501839.99% in 2022, then jumped by 100 bps to 801.03% in 2023, then surged by 90 bps to 81.21% in 2024.
  • According to Business Quant data, EBT Margin over the past three periods registered 81.21%, 124.82%, and 213.92% for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 35.61%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 35.71%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -528.97%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 18.33%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 13.77%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -25.06%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -2.67%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 12.09%
10 Moolec Science 8,617.72 -1.19 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -81.21%
Sep 30, 2024 -124.82%
Jun 30, 2024 -213.92%
Mar 31, 2024 -60.44%
Dec 31, 2023 -801.03%
Sep 30, 2023 -103.81%
Jun 30, 2023 9.74%
Mar 31, 2023 1,271.78%
Dec 31, 2022 -501,839.99%
Sep 30, 2022 6,273.27%
Jun 30, 2022 -74,622.65%
Mar 31, 2022 4,379.63%